Inspec

Inspec EV/Revenue

The EV/Revenue (Enterprise Value to Revenue) of Inspec (6656.T) as of Oct 27, 2026 is 1.69. In the previous year, EV/Revenue (Enterprise Value to Revenue) was 1.60 — a change of 5.28% (higher).

EV/Revenue

1.69

YoY

5.28%

Last updated:

EV/Revenue (Enterprise Value to Revenue) of Inspec is 2026 1.69 . EV/Revenue (Enterprise Value to Revenue) of Inspec was 2025 1.60 . It decreases by 5.28% higher compared to the previous year.

The Inspec EV/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/Revenue
Date
EV/Revenue
Jan 1, 2019
0.82 JPY
Jan 1, 2020
1.45 JPY
Jan 1, 2021
2.38 JPY
Jan 1, 2022
2.00 JPY
Jan 1, 2023
1.77 JPY
Jan 1, 2024
2.43 JPY
Jan 1, 2025
1.60 JPY
Jan 1, 2026
1.69 JPY
The Inspec EV/Revenue history
YEAREV/RevenueYoY
1.69+5.28%
1.60-34.01%
2.43+37.36%
1.77-11.57%
2.00-15.79%
2.38+64.37%
1.45+76.07%
0.82-46.04%
1.52+29.20%
1.18-37.34%
1.88-6.10%
2.00-23.67%
2.62—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

EV/Revenue (Enterprise Value to Revenue) of Inspec is 1.69 in 2026.

EV/Revenue (Enterprise Value to Revenue) of Inspec changed from 1.60 to 1.69, representing a 5.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/Revenue (Enterprise Value to Revenue) Inspec since 2006 – with annual values, charts, and detailed analysis.

The EV/Revenue ratio compares a company's enterprise value to its total revenue. It is particularly useful for valuing high-growth companies that may not yet be profitable.

To evaluate EV/Revenue (Enterprise Value to Revenue)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/Revenue (Enterprise Value to Revenue).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/Revenue (Enterprise Value to Revenue)'s Inspec with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Inspec

All Key Metrics — Inspec